Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P56851 (
epididymal
)
11,273
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
During the haematogenous dissemination of this acute rat T-cell (Roser) leukaemia, infiltration of both
epididymal
and testicular interstitial tissue has now been demonstrated, probably as an invariable occurrence. The gonadal duct system itself was not invaded. In contrast to an earlier histopathological study with this leukaemia, meningeal invasion has also been encountered during routine passage. Furthermore, subsequent to remissions induced by carmustine (
BCNU
), relapse could occur as long as 80 days after the 20 day end point in control animals. This was associated with extensive infiltration of the meninges as well as in the male gonadal interstitium, the proximal epididymis being particularly vulnerable. Two doses of carmustine at intervals of one week could eradicate the disease even during the phase of logarithmic growth of the leukaemic cells, this result depending upon the level of treatment and time of dosing post-inoculation with leukaemic cells. Females carrying the disease were shown to be more readily cured than males, probably related to entry of leukaemia cells into the gonadal interstitium. This T-cell leukaemia appears to be an excellent model for the study and prospective chemotherapy of testicular relapse in acute lymphoblastic leukaemia.
...
PMID:Testicular invasion and relapse and meningeal involvement in a rat T-cell leukaemia. 633 87
The disappearance of 1,3-bis(2-chlorethyl)-1-nitrosourea (
BCNU
) from plasma, liver, kidney, lung, brain, spleen, tumor tissue and
epididymal
adipose tissue of Walker 256/B carcinoma-bearing rats and healthy animals was measured by differential pulse polarography after i.v. bolus of the drug. Only
BCNU
, not its decomposition products, was detected by the polarographic assay. Levels of
BCNU
in liver of tumor-bearing animals were significantly lower (about 10 times) than those on healthy rats. A bi-exponential fit was used to calculate the kinetics of
BCNU
in plasma, kidney, lung and brain, but no difference could be found between healthy and Walker tumor-bearing rats.
BCNU
disappeared faster from adipose tissue of tumor-bearing animals than from normals.
...
PMID:Pharmacokinetics of nitrosoureas: levels of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after i.v. bolus. 653 91